- 2024-11-17 18:12DDD489
- 2024-11-17 18:12IMPDH2-IN-4
- 2024-11-17 18:12AR89-d6
- 2024-11-17 18:12PROTAC HDAC8 Degrader-2
- 2024-11-17 18:11Navepdekinra
- 2024-11-17 18:11Rosolutamide
- 2024-11-17 18:11PXR Ligand 2
- 2024-11-17 18:11SARS-CoV-2 Mpro-IN-28
- 2024-11-17 18:11DNA-PK-IN-15
- 2024-11-17 18:11Xibornol
- 2024-11-17 18:11PRL3-CNNM4 interaction-IN-1
- 2024-11-17 18:11Antitumor agent-187
- 2024-11-17 18:11SARS-CoV-2 3CLpro-IN-27
- 2024-11-17 18:11B32B3
- 2024-11-17 18:11LT25
- 2024-11-17 18:11B7-33
- 2024-11-17 18:11RGS2–Galpha-q interaction-IN-1
- 2024-11-17 18:10PROTAC SMARCA2 degrader-23
- 2024-11-17 18:10FX-171-C
- 2024-11-17 18:10N-MeVal-Val-Dil-Dap-2-(pyridin-3-yl)ethanamine
